Chemistry:Cipemastat

From HandWiki
Revision as of 11:47, 2 May 2023 by Sherlock (talk | contribs) (over-write)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Cipemastat
Cipemastat.svg
Names
Preferred IUPAC name
(2R,3R)-3-(Cyclopentylmethyl)-N-hydroxy-4-oxo-4-(piperidin-1-yl)-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
Properties
C22H36N4O5
Molar mass 436.553 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references
Tracking categories (test):

Cipemastat (rINN, also known as Ro 32-3555 and by the tentative trade name Trocade) is a selective inhibitor of matrix metalloproteinase-1 that has been investigated as an anti-arthritis agent.[1] It is being developed by Roche.

References

  1. "Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis". Rheumatology (Oxford) 40 (5): 537–43. 2001. doi:10.1093/rheumatology/40.5.537. PMID 11371662.